FINWIRES · TerminalLIVE
FINWIRES

最新情報：ベクトン・ディキンソンの株価は第2四半期決算好調を受けて上昇。ヴィトール・ロケ氏がCFOに就任。

By

-- （最初の段落と見出しに最新の株価動向を追記しました。） ベクトン・ディキンソン（BDX）の株価は、同社が第2四半期決算で好業績を発表し、ヴィトール・ロケ氏をCFOに任命したことを受け、木曜日の取引で5.6%上昇しました。 同社は木曜日、第2四半期の調整後希薄化後1株当たり利益が前年同期の2.79ドルから2.90ドルに増加したと発表しました。 FactSetが調査したアナリストは2.78ドルを予想していました。 3月31日締めの四半期の売上高は47億1000万ドルで、前年同期の44億8000万ドルから増加しました。 FactSetが調査したアナリストは46億7000万ドルを予想していました。 同社は2026年の調整後希薄化後1株当たり利益の見通しを、従来の12.35ドル～12.65ドルから12.52ドル～12.72ドルに引き上げました。FactSetが調査したアナリストは12.49ドルを予想していました。同社は、売上高成長率の見通しを1桁台前半に据え置いた。 また、同社は暫定最高財務責任者（CFO）を務めていたヴィトール・ロケ氏を、即日付けで正式にCFOに任命したと発表した。 ベクトン・ディキンソン社によると、ロケ氏は25年以上の経験を持ち、同社で財務および事業運営における要職を歴任してきた。

Price: $153.28, Change: $+8.52, Percent Change: +5.88%

Related Articles

Insider Trading

Teva Pharmaceutical Industries Insider Sold Shares Worth $384,444, According to a Recent SEC Filing

Amir Weiss, Chief Accounting Officer, on May 06, 2026, sold 10,679 shares in Teva Pharmaceutical Industries (TEVA) for $384,444. Following the Form 4 filing with the SEC, Weiss has control over a total of 20,016 ordinary shares of the company, with 20,016 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/818686/000119312526211855/xslF345X05/ownership.xml

$TEVA
Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Doordash, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our price target by $2 to $240, based on 30x our 2027 EPS view, just below DASH's three-year average (~32x) given competitive threats from AI and Uber Eats, offset by the company's dominant market position and positive network effects. We raise our 2026 adjusted EPS view by $0.10 to $5.63 and 2027's by $0.06 to $7.99. We are encouraged by DASH's Q2 Marketplace GOV guidance (+36% Y/Y), an encouraging result following relatively soft guidance for Q1, especially given fears of a weakening consumer. International sales continue to scale solidly, with Deliveroo accelerating to 14% Y/Y growth in Q1 vs. 7% growth in Q4 (we expect continued improvement all year). Margin pressure remains (adjusted EBITDA margin -20 bps Y/Y to 2.4%) but should fade as platform integration activities finish up early next year. Adjusted EBITDA guidance (midpoint of $820M) was above expectations ($742M), despite the company expecting another $50M gas relief charge, which should persist amid the Strait of Hormuz closure.

$DASH
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Tyson Foods, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target remains $76, a 15x multiple of projected FY 27 EPS of $5.09 (raised by $0.02). We also lift our FY 26 (Sep.) EPS est. by $0.09 to $4.11. This multiple is slightly above TSN's long-term average of 14x, reflecting favorable secular tailwinds, including a continued shift in consumer preferences toward protein and improved earnings growth potential as the Beef segment recovers, likely in FY 27. Operationally, TSN is executing well, particularly in Chicken, where margins continue to widen, up 290 bps year over year in FQ2. Beef remains pressured by historically tight cattle supplies, with the U.S. herd at its lowest level since 1951, though we expect margins to improve following recent restructuring actions, including rightsizing production to improve capacity utilization. TSN's balance sheet is solid, noting its leverage ratio (net debt/adjusted EBITDA) has now improved to 2.2x vs. 3.9x two years ago. This provides a decent degree of financial flexibility in our view.

$TSN